Liraglutide Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Liraglutide Injection (injection) from Novo Nordisk, Inc. with status Current. The shortage was first posted on Jul 18, 2023.
Shortage details
- Status
- Current
- Company
- Novo Nordisk, Inc.
- Package NDC
- 0480-3667-20
- Dosage Form
- Injection
- Presentation
- Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-20)
- Initial Posting
- Jul 18, 2023